home All News open_in_new Full Article

JLR to resume some manufacturing in coming days after hack: GSK shares rise 3% after surprise CEO change – business live

JLR says “controlled, phased restart” of its operations continues, as GSK appoints a new boss to succeed Dame Emma Walmsley.GSK’s Emma Walmsley to be replaced as chief executiveInside the Jaguar Land Rover hack: stalled smart factories, outsourced cybersecurity and supply chain woesEmma Walmsley’s departure as CEO of GSK at the end of the year will be the “end of an era”, says Derren Nathan, head of equity research at Hargreaves Lansdown.Nathan explains:“The first ever female CEO of a major pharmaceutical company, Dame Emma Walmsley, is set to hand over GSK’s reins on New Year’s Day 2026. One of her key achievements was the demerger of Haleon, the company behind consumer health brands such as Beechams. That not just strengthened GSK’s balance sheet but also sharpened the group’s focus on speciality medicines and vaccines. There’s an exciting pipeline ahead and, this year alone, GSK’s on track for five major regulatory approvals. Her reign also saw a line drawn in the sand in the Zan...


today 4 d. ago attach_file Economics

attach_file Politics
attach_file Economics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Economics
attach_file Politics
attach_file Events
attach_file Events
attach_file Economics
attach_file Economics
attach_file Economics
attach_file Economics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Economics
attach_file Economics
attach_file Society
attach_file Events


ID: 1651906890
Add Watch Country

arrow_drop_down